OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.

Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y

Open source

DOI
10.1002/ijc.25643
Published
2011 Jun 1
Container
International journal of cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.25643,
  title = {OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.},
  author = {Asadi MH and Mowla SJ and Fathi F and Aleyasin A and Asadzadeh J and Atlasi Y},
  year = {2011},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.25643},
  url = {https://doi.org/10.1002/ijc.25643}
}

RIS

TY  - JOUR
TI  - OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
AU  - Asadi MH
AU  - Mowla SJ
AU  - Fathi F
AU  - Aleyasin A
AU  - Asadzadeh J
AU  - Atlasi Y
PY  - 2011
JO  - International journal of cancer
DO  - 10.1002/ijc.25643
UR  - https://doi.org/10.1002/ijc.25643
ER  - 

APA

MH, A., SJ, M., F, F., A, A., J, A., & Y, A. (2011). OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.. International journal of cancer. https://doi.org/10.1002/ijc.25643

Source records